Figures computed from official regulatory filings — .
Ownershipinsiders 86.03% · institutions 0%
In USD · as of Oct 26, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NIKA PHARMACEUTICALS, INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
Market information source · Oct 26, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 26, 2026
Open-market timeline · full history
1 buy7 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Savov Dimitar Slavchev | Sell | $500K | SEC | ||
| NIKA PHARMACEUTICALS, INC |
| Other |
| n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) |
| SEC |
| NIKA PHARMACEUTICALS, INC | Sell | $70K | SEC |
| NIKA PHARMACEUTICALS, INC | Sell | $140K | SEC |
| NIKA PHARMACEUTICALS, INC | Sell | $120K | SEC |
| NIKA PHARMACEUTICALS, INC | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| NIKA PHARMACEUTICALS, INC | Sell | $15K | SEC |
| NIKA PHARMACEUTICALS, INC | Sell | $63K | SEC |
| NIKA PHARMACEUTICALS, INC | Other | $30T | SEC |
| NIKA PHARMACEUTICALS, INC | Sell | $25K | SEC |
| NIKA PHARMACEUTICALS, INC | Other | $250B | SEC |
| NIKA PHARMACEUTICALS, INC | Buy | $114.9K | conv 57First in 12mo | SEC |